US Patent Issued to NEUROCARE GROUP on Feb. 24 for "Body-condition-dependent stimulation with real-time communication between an action module and a capture module" (German Inventors)

ALEXANDRIA, Va., Feb. 24 -- United States Patent no. 12,562,269, issued on Feb. 24, was assigned to NEUROCARE GROUP AG (Munich).

"Body-condition-dependent stimulation with real-time communication between an action module and a capture module" was invented by Sebastian Berkes (Ilmenau, Germany), Patrick Stein (Ilmenau, Germany) and Klaus Schellhorn (Ilmenau, Germany).

According to the abstract* released by the U.S. Patent & Trademark Office: "The invention relates to a system for body-condition-dependent stimulation by means of function modules, e.g. an action module (2, D/A module) for stimulating tissue and a capture module (3, A/D module) for deriving/measuring bio data or bio signals, characterized in that the two modules communicate v...